Literature DB >> 24815484

Colorectal carcinoma in Malaysians: DNA mismatch repair pattern in a multiethnic population.

Phaik-Leng Cheah1, Lai-Meng Looi, Kean-Hooi Teoh, Nazarina Abdul Rahman, Li-Xuan Wong, Soo-Yong Tan.   

Abstract

BACKGROUND: The interesting preponderance of Chinese with colorectal carcinoma (CRC) amongst the three major ethnic groups in Malaysia prompted a study to determine DNA mismatch repair (MMR) status in our CRC and attempt correlation with patient age, gender and ethnicity as well as location, grade, histological type and stage of tumour. Histologically re-confirmed CRC, diagnosed between 1st January 2005 and 31st December 2007 at the Department of Pathology, University of Malaya Medical Centre, were immunohistochemically stained with monoclonal antibodies to MMR proteins, MLH1, MSH2, MSH6 and PMS2 on the Ventana Benchmark XT autostainer. Of the 142 CRC cases entered into the study, there were 82 males and 60 females (M:F=1.4:1). Ethnically, 81 (57.0%) were Chinese, 32 (22.5%) Malays and 29 (20.4%) Indians. The patient ages ranged between 15-87 years (mean=62.4 years) with 21 cases <50-years and 121 ≥50-years of age. 14 (9.9%) CRC showed deficient MMR (dMMR). Concurrent loss of MLH1 and PMS2 occurred in 10, MSH2 and MSH6 in 2 with isolated loss of MSH6 in 1 and PMS2 in 1. dMMR was noted less frequently amongst the Chinese (6.2%) in comparison with their combined Malay and Indian counterparts (14.8%), and was associated with right sided and poorly differentiated tumours (p<0.05). 3 of the 5 (60.0%) dMMR CRC cases amongst the Chinese and 1 of 9 cases (11.1%) amongst the combined Malay and Indian group were <50-years of age. No significant association of dMMR was noted with patient age and gender, tumour stage or mucinous type.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24815484     DOI: 10.7314/apjcp.2014.15.7.3287

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

1.  Low prevalence of mismatch repair deficiency in Chinese colorectal cancers: a multicenter study.

Authors:  Wu Jiang; Qiao-Qi Sui; Wen-Liang Li; Chuan-Feng Ke; Yi-Hong Ling; Le-En Liao; Zhu Zhu; Mu-Yan Cai; Jun Luo; Lin-Lin Mao; Hui-Zhong Zhang; De-Sen Wan; Zhi-Zhong Pan; Hai-Xing Ju; Pei-Rong Ding
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-04-10

2.  Chemopreventive efficacy of Andrographis paniculata on azoxymethane-induced aberrant colon crypt foci in vivo.

Authors:  Nawal Al-Henhena; Rozaida Poh Yuen Ying; Salmah Ismail; Walaa Najm; Wala Najm; Shaden A M Khalifa; Hesham El-Seedi; Mahmood Ameen Abdulla; Mahmood Ameen Abdulla
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

3.  Prediction of biological behavior and prognosis of colorectal cancer patients by tumor MSI/MMR in the Chinese population.

Authors:  Wen-Yue Yan; Jing Hu; Li Xie; Lei Cheng; Mi Yang; Li Li; Jiong Shi; Bao-Rui Liu; Xiao-Ping Qian
Journal:  Onco Targets Ther       Date:  2016-12-08       Impact factor: 4.147

4.  Dickkopf-related protein 1, a new biomarker for local immune status and poor prognosis among patients with colorectal liver Oligometastases: a retrospective study.

Authors:  Qiaoqi Sui; Jian Zheng; Dingxin Liu; Jianhong Peng; Qingjian Ou; Jinghua Tang; Yuan Li; Lingheng Kong; Wu Jiang; Binyi Xiao; Xue Chao; Zhizhong Pan; Huizhong Zhang; Pei-Rong Ding
Journal:  BMC Cancer       Date:  2019-12-12       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.